Modifying Antiretroviral Therapy in Virologically Suppressed HIV-Infected Patients

  • Author: José R. Arribas, MD (More Info)
  • Section Editor: Eric S. Daar, MD
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/18/21 (What's New)

Supporting Assets

Table 1 | Table 2

Table 1. Modifying ART to Increase Tolerability and/or Decrease Toxicity

Toxicity/Tolerability or Comorbidity of Concern

Offending Agent(s)

Switches Supported by Clinical Trial Evidence

Results

Bone health

Tenofovir DF

Improved bone parameters

Improvement in bone-specific alkaline phosphatase, osteocalcin, precollagen 1 N-terminal propeptide, type 1 collagen cross-linked C-telopeptide

 

Cardiovascular disease

Abacavir/lamivudine

 

Decrease in lipid parameters

Boosted PI

 

CNS toxicity

Efavirenz

 

Decreased of central nervous system adverse events

Dyslipidemia

Abacavir/lamivudine

 

↓ TC, LDL

Lopinavir/ritonavir

 

 

 

↓ TC, TGs, LDL, TC:HDL ratio

Ritonavir-boosted PI

↓ TC, TGs, LDL, non-HDL, TC:HDL ratio

↓ LDL, non-HDL

↓ TC, TGs, LDL, TC:HDL ratio

Lipid parameters decreased

Renal impairment

Tenofovir DF

Improved proximal tubular function endpoints

Weight gain

All INSTIs

Currently unproven; clinical trials ongoing

CNS, central nervous system; HDL, high-density lipoprotein LDL, low-density lipoprotein; TC, total cholesterol; TG, triglycerides.
 *Currently being investigated in clinical trial.

...

Action required

Keywords: Switch Strategies

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.